In the year 2022, the global virus filtration market boasted an impressive valuation, standing at an approximate sum of USD 4.30 billion.

It is projected to experience a steady growth trajectory with a compound annual growth rate (CAGR) of 10.3% from 2023 to 2030.

Biopharmaceutical companies are among the major end-users of virus filtration products and services.

The COVID-19 pandemic has further highlighted the importance of virus filtration in ensuring the safety of pharmaceutical products and vaccines.